Midkine positively regulates the proliferation of human gastric cancer cells

被引:44
作者
Xu, Yingying [1 ]
Qu, Xiujuan [1 ]
Zhang, Xue [2 ,3 ]
Luo, Yang [2 ,3 ]
Zhang, Ye [1 ]
Luo, Ying [1 ]
Hou, Kezuo [1 ]
Liu, Yunpeng [1 ]
机构
[1] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang 110001, Peoples R China
[2] China Med Univ, Res Ctr Med Genom, Shenyang 110001, Peoples R China
[3] China Med Univ, MOH Key Lab Cell Biol, Shenyang 110001, Peoples R China
基金
中国国家自然科学基金;
关键词
Midkine; Gastric cancer; Akt; ERK1/2; Cell cycle; CLINICAL-SIGNIFICANCE; DOWN-REGULATION; GROWTH-FACTORS; EXPRESSION; APOPTOSIS; OVEREXPRESSION; TRANSFORMATION; PATHWAY; PHOSPHORYLATION; ACTIVATION;
D O I
10.1016/j.canlet.2009.01.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Midkine (MDK), a heparin-binding growth factor, modulates the proliferation and migration of various cells, is often highly expressed in many malignant tumors, and may act as an oncoprotein. We found that MDK is overexpressed in clinical human gastric cancer tissues relative to its expression in adjacent noncancerous tissues. To further investigate the biological activities of MDK in gastric cancer, we introduced the MDK gene into human SGC7901 gastric cancer cells, where it contributed to the proliferation of SGC7901 cells in vitro and in vivo. Conversely, the knockdown of MDK expression by siRNA resulted in significantly reduced proliferation of BGC823 cells. Our study also shows that MDK activates both the Akt and ERK1/2 pathways and upregulates the expression of several cell-cycle-related proteins, including cyclin A, cyclin D1, Cdk2, Cdk4, and Cdk6, which in part explains the contribution of MDK to gastric cancer cell survival and growth. These results demonstrate that MDK contributes to gastric cancer cell proliferation and suggest that it plays an important role in the development of human gastric cancer. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:137 / 144
页数:8
相关论文
共 42 条
  • [1] GROWTH-FACTORS AND CANCER
    AARONSON, SA
    [J]. SCIENCE, 1991, 254 (5035) : 1146 - 1153
  • [2] Gastric cancer: epidemiology, pathology and treatment
    Alberts, SR
    Cervantes, A
    van de Velde, CJH
    [J]. ANNALS OF ONCOLOGY, 2003, 14 : 31 - 36
  • [3] INCREASED MIDKINE GENE-EXPRESSION IN HUMAN GASTROINTESTINAL CANCERS
    ARIDOME, K
    TSUTSUI, J
    TAKAO, S
    KADOMATSU, K
    OZAWA, M
    AIKOU, T
    MURAMATSU, T
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (07): : 655 - 661
  • [4] Midkine is an autocrine activator of signal transducer and activator of transcription 3 in 3T3-L1 cells
    Cernkovich, Erin R.
    Deng, Jianbei
    Hua, Kunjie
    Harp, Joyce B.
    [J]. ENDOCRINOLOGY, 2007, 148 (04) : 1598 - 1604
  • [5] Molecular biology of gastric cancer
    Cervantes, A.
    Braun, E. Rodriguez
    Fidalgo, A. Perez
    Gonzalez, I. Chirivella
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (04) : 208 - 215
  • [6] Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
    Chang, F
    Lee, JT
    Navolanic, PM
    Steelman, LS
    Shelton, JG
    Blalock, WL
    Franklin, RA
    McCubrey, JA
    [J]. LEUKEMIA, 2003, 17 (03) : 590 - 603
  • [7] Midkine and LDL-receptor-related protein 1 contribute to the anchorage-independent cell growth of cancer cells
    Chen, Sen
    Bu, Guojun
    Takei, Yoshifumi
    Sakamoto, Kazuma
    Ikematsu, Shinya
    Muramatsu, Takashi
    Kadomatsu, Kenji
    [J]. JOURNAL OF CELL SCIENCE, 2007, 120 (22) : 4009 - 4015
  • [8] delPeso L, 1997, SCIENCE, V278, P687
  • [9] Glycogen synthase kinase 3β regulates cyclin D1 proteolysis and subcellular localization
    Diehl, JA
    Cheng, MG
    Roussel, MF
    Sherr, CJ
    [J]. GENES & DEVELOPMENT, 1998, 12 (22) : 3499 - 3511
  • [10] Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway
    Fang, XJ
    Yu, SX
    Eder, A
    Mao, ML
    Bast, RC
    Boyd, D
    Mills, GB
    [J]. ONCOGENE, 1999, 18 (48) : 6635 - 6640